Citatuzumab bogatox
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Humanized (from mouse) |
Target | TACSTD1 |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 945228-49-9 |
ChemSpider | none |
UNII | 23J303Z5CA |
Chemical and physical data | |
Formula | C3455H5371N921O1060S18 |
Molar mass | 77.3 kg/mol |
(what is this?) (verify) |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Viventia Biotech Inc.: VB6-845
This article is issued from Wikipedia - version of the 11/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.